Claritev Corporation/$CTEV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Claritev Corporation
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Ticker
$CTEV
Sector
Primary listing
NYSE
Employees
2,700
Headquarters
Website
CTEV Metrics
BasicAdvanced
$986M
-
-$40.80
0.58
-
Price and volume
Market cap
$986M
Beta
0.58
52-week high
$74.07
52-week low
$4.80
Average daily volume
135K
Financial strength
Current ratio
0.976
Quick ratio
0.786
Long term debt to equity
-11,608.873
Total debt to equity
-11,656.873
Interest coverage (TTM)
0.22%
Profitability
EBITDA (TTM)
517.597
Gross margin (TTM)
74.43%
Net profit margin (TTM)
-70.91%
Operating margin (TTM)
8.39%
Effective tax rate (TTM)
14.69%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
0.73%
Return on equity (TTM)
-235.47%
Valuation
Price to revenue (TTM)
1.041
Price to book
-24.71
Price to tangible book (TTM)
-0.22
Price to free cash flow (TTM)
-17.697
Free cash flow yield (TTM)
-5.65%
Free cash flow per share (TTM)
-3.383
Growth
Revenue change (TTM)
-2.03%
Earnings per share change (TTM)
-43.66%
3-year revenue growth (CAGR)
-7.31%
3-year earnings per share growth (CAGR)
59.80%
Bulls say / Bears say
Claritev’s February 17, 2025 name change from MultiPlan signals its strategic transformation and renewed focus on innovation, expanding its value-added data analytics and technology-enabled solutions (SEC)
In Q2 2025, Claritev returned to year-over-year revenue growth—up 3.5% to $241.6 million—mainly due to strength in its network-based and payment & revenue integrity services (SEC)
Claritev’s improved operational execution boosted cash generation, with net cash from operating activities rising to $61.2 million in Q2 2025 from $18.5 million in Q2 2024, strengthening its liquidity position (SEC)
The U.S. Justice Department supported antitrust lawsuits from medical providers claiming that Claritev’s use of a common pricing algorithm could breach federal law, putting the company at significant legal and reputational risk (Reuters)
A U.S. judge ruled that Claritev and major insurers must face combined claims alleging they conspired to underpay out-of-network providers, raising the risk of expensive litigation and possible damages (Reuters)
As of June 30, 2025, Claritev’s total debt was $4.59 billion and its quarterly interest expense increased 23% to $99.7 million, putting more pressure on cash flow and increasing refinancing risk (SEC)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.
CTEV News
AllArticlesVideos
Claritev Earns 2025 Great Place To Work® Certification™ and Makes Fortune's Best Workplaces in Health Care™ List Again
Business Wire5 days ago
Claritev Corporation Reports Second Quarter 2025 Results
Business Wire1 month ago
Claritev Joins athenahealth's Marketplace Program to Empower Providers with Price Intelligence for Stronger Financial Outcomes
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Claritev Corporation stock?
Claritev Corporation (CTEV) has a market cap of $986M as of September 16, 2025.
What is the P/E ratio for Claritev Corporation stock?
The price to earnings (P/E) ratio for Claritev Corporation (CTEV) stock is 0 as of September 16, 2025.
Does Claritev Corporation stock pay dividends?
No, Claritev Corporation (CTEV) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Claritev Corporation dividend payment date?
Claritev Corporation (CTEV) stock does not pay dividends to its shareholders.
What is the beta indicator for Claritev Corporation?
Claritev Corporation (CTEV) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.